Related Experiment Videos
[Vitreous hemorrhage: attitudes in therapy, vitrectomy]
A Mathis1, V Pagot, F Malecaze
1Service d'Ophtalmologie, CHU Rangueil, Toulouse, France.
Diabete & Metabolisme
|September 1, 1993
Summary
Vitreous hemorrhage, a complication of proliferative diabetic retinopathy, can hinder laser treatment. Pars plana vitrectomy is now a key treatment for severe cases, offering improved outcomes.
Area of Science:
- Ophthalmology
- Diabetic Retinopathy Management
Background:
- Vitreous hemorrhage is a severe complication of proliferative diabetic retinopathy.
- It indicates advanced retinopathy and can prevent laser photocoagulation.
Purpose of the Study:
- To review the management of vitreous hemorrhage in proliferative diabetic retinopathy.
- To highlight the role of pars plana vitrectomy in severe cases.
Main Methods:
- Review of treatment modalities for vitreous hemorrhage.
- Discussion of indications for pars plana vitrectomy.
Main Results:
- Panretinal photocoagulation may be possible in moderate vitreous hemorrhage using specific wavelengths or cryotherapy.
- Pars plana vitrectomy has become the primary treatment for severe vitreous hemorrhage.
- Indications for vitrectomy have expanded due to improved techniques and observed benefits.
Conclusions:
- Pars plana vitrectomy is crucial for managing severe vitreous hemorrhage in diabetic retinopathy.
- Factors like bilaterality, iris neovascularization, and diabetes type influence treatment decisions.